Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Respiration, Artificial | 37 | 2021 | 22116 | 1.92 | Why? |
Positive-Pressure Respiration | 13 | 2021 | 1160 | 1.68 | Why? |
Ventilator-Induced Lung Injury | 7 | 2019 | 260 | 1.55 | Why? |
Developing Countries | 18 | 2021 | 4283 | 1.38 | Why? |
Tidal Volume | 10 | 2021 | 565 | 1.34 | Why? |
Sepsis | 17 | 2019 | 3517 | 1.28 | Why? |
Intensive Care Units | 37 | 2021 | 29594 | 1.02 | Why? |
Critical Care | 15 | 2020 | 14081 | 0.92 | Why? |
Pneumonia, Ventilator-Associated | 5 | 2017 | 861 | 0.82 | Why? |
Pulmonary Atelectasis | 1 | 2020 | 80 | 0.78 | Why? |
Ventilators, Mechanical | 6 | 2021 | 2193 | 0.77 | Why? |
Tracheostomy | 6 | 2021 | 1963 | 0.76 | Why? |
Health Resources | 6 | 2020 | 2592 | 0.72 | Why? |
Postoperative Complications | 10 | 2019 | 5861 | 0.71 | Why? |
Critical Care Outcomes | 1 | 2018 | 138 | 0.69 | Why? |
Protein C | 3 | 2017 | 141 | 0.69 | Why? |
Pulmonary Medicine | 3 | 2020 | 706 | 0.68 | Why? |
Respiratory System Agents | 1 | 2018 | 63 | 0.66 | Why? |
Ultrasonography | 5 | 2021 | 4409 | 0.65 | Why? |
Practice Guidelines as Topic | 13 | 2021 | 15421 | 0.60 | Why? |
Respiratory Insufficiency | 7 | 2021 | 7301 | 0.59 | Why? |
Ventilator Weaning | 4 | 2018 | 536 | 0.55 | Why? |
Lung | 18 | 2021 | 31049 | 0.52 | Why? |
Critical Illness | 16 | 2021 | 17281 | 0.51 | Why? |
Burns | 1 | 2019 | 466 | 0.48 | Why? |
Continuous Positive Airway Pressure | 2 | 2021 | 1187 | 0.46 | Why? |
Health Services Research | 1 | 2018 | 756 | 0.45 | Why? |
Respiratory Mechanics | 5 | 2021 | 585 | 0.44 | Why? |
Respiratory Therapy | 1 | 2018 | 918 | 0.42 | Why? |
Oxygen | 3 | 2021 | 3715 | 0.42 | Why? |
Anesthesia | 2 | 2018 | 1236 | 0.42 | Why? |
Blood Glucose | 4 | 2017 | 3642 | 0.41 | Why? |
Netherlands | 12 | 2021 | 3533 | 0.41 | Why? |
Home Care Services | 1 | 2021 | 1351 | 0.40 | Why? |
Glycemic Index | 1 | 2010 | 115 | 0.39 | Why? |
Quality of Health Care | 2 | 2018 | 1948 | 0.39 | Why? |
Quality Improvement | 3 | 2018 | 2435 | 0.39 | Why? |
Gastrointestinal Tract | 1 | 2017 | 1113 | 0.37 | Why? |
Oropharynx | 1 | 2017 | 1581 | 0.36 | Why? |
Health Care Costs | 1 | 2017 | 1007 | 0.36 | Why? |
Decontamination | 1 | 2017 | 1196 | 0.34 | Why? |
Abdomen | 4 | 2018 | 424 | 0.34 | Why? |
Humans | 116 | 2021 | 930598 | 0.34 | Why? |
Hemofiltration | 1 | 2009 | 155 | 0.33 | Why? |
Hypothermia, Induced | 2 | 2019 | 176 | 0.32 | Why? |
Hypoventilation | 1 | 2005 | 17 | 0.30 | Why? |
Blood Coagulation | 3 | 2021 | 2768 | 0.30 | Why? |
Hemodynamics | 3 | 2018 | 1562 | 0.30 | Why? |
Thailand | 2 | 2020 | 1155 | 0.30 | Why? |
Guideline Adherence | 1 | 2018 | 2309 | 0.30 | Why? |
Breath Tests | 3 | 2017 | 338 | 0.29 | Why? |
Pneumonia, Pneumococcal | 2 | 2018 | 251 | 0.29 | Why? |
Postoperative Care | 1 | 2010 | 755 | 0.28 | Why? |
Lung Diseases | 4 | 2019 | 2361 | 0.28 | Why? |
Muscle Weakness | 2 | 2018 | 406 | 0.27 | Why? |
Coronary Artery Bypass | 1 | 2010 | 629 | 0.27 | Why? |
Evidence-Based Medicine | 3 | 2020 | 3228 | 0.26 | Why? |
Time-to-Treatment | 1 | 2020 | 5883 | 0.26 | Why? |
Shock, Septic | 3 | 2017 | 1313 | 0.25 | Why? |
Anesthesia, General | 2 | 2018 | 470 | 0.25 | Why? |
Triage | 2 | 2021 | 7151 | 0.25 | Why? |
Blood Glucose Self-Monitoring | 1 | 2008 | 791 | 0.24 | Why? |
Rewarming | 2 | 2019 | 11 | 0.24 | Why? |
Disease Management | 4 | 2021 | 6841 | 0.24 | Why? |
Tuberculosis | 1 | 2018 | 2895 | 0.24 | Why? |
Monitoring, Physiologic | 3 | 2018 | 1956 | 0.24 | Why? |
Probiotics | 1 | 2010 | 694 | 0.24 | Why? |
Inflammation Mediators | 3 | 2018 | 2654 | 0.23 | Why? |
Respiratory Dead Space | 1 | 2021 | 36 | 0.23 | Why? |
Patient Admission | 1 | 2018 | 5250 | 0.23 | Why? |
Cross Infection | 3 | 2019 | 8675 | 0.22 | Why? |
Betacoronavirus | 10 | 2020 | 204454 | 0.22 | Why? |
Pneumonia, Viral | 10 | 2020 | 243684 | 0.22 | Why? |
Coronavirus Infections | 10 | 2020 | 253789 | 0.21 | Why? |
Drug Utilization | 1 | 2006 | 619 | 0.21 | Why? |
Prone Position | 3 | 2021 | 1861 | 0.21 | Why? |
Volatile Organic Compounds | 3 | 2017 | 187 | 0.21 | Why? |
Virus Diseases | 1 | 2018 | 3779 | 0.20 | Why? |
Smoke Inhalation Injury | 1 | 2019 | 22 | 0.20 | Why? |
Prospective Studies | 17 | 2019 | 43301 | 0.20 | Why? |
Receptor for Advanced Glycation End Products | 2 | 2018 | 100 | 0.20 | Why? |
Serum Bactericidal Test | 1 | 2018 | 7 | 0.20 | Why? |
Minimally Invasive Surgical Procedures | 1 | 2005 | 663 | 0.20 | Why? |
Postoperative Period | 2 | 2018 | 651 | 0.19 | Why? |
Recombinant Proteins | 2 | 2009 | 3786 | 0.19 | Why? |
Hypothermia | 1 | 2019 | 59 | 0.19 | Why? |
HMGB1 Protein | 1 | 2021 | 223 | 0.19 | Why? |
Delphi Technique | 2 | 2021 | 1257 | 0.19 | Why? |
Receptor, PAR-2 | 1 | 2018 | 27 | 0.18 | Why? |
Imatinib Mesylate | 1 | 2021 | 327 | 0.18 | Why? |
Delivery of Health Care | 3 | 2021 | 15909 | 0.18 | Why? |
Intraabdominal Infections | 1 | 2019 | 90 | 0.18 | Why? |
Perioperative Care | 2 | 2020 | 1329 | 0.18 | Why? |
Barotrauma | 1 | 2019 | 97 | 0.18 | Why? |
Safety | 2 | 2020 | 1583 | 0.17 | Why? |
Randomized Controlled Trials as Topic | 4 | 2018 | 10649 | 0.17 | Why? |
Male | 46 | 2021 | 367725 | 0.17 | Why? |
Electronic Nose | 1 | 2017 | 36 | 0.17 | Why? |
Albuterol | 1 | 2018 | 105 | 0.17 | Why? |
Protein Kinase Inhibitors | 2 | 2021 | 1585 | 0.17 | Why? |
Neuromuscular Blocking Agents | 1 | 2018 | 121 | 0.17 | Why? |
Hypoglycemia | 3 | 2017 | 406 | 0.17 | Why? |
Fibrinolytic Agents | 1 | 2009 | 1702 | 0.17 | Why? |
Hospitalization | 4 | 2021 | 54280 | 0.17 | Why? |
Berlin | 1 | 2017 | 283 | 0.17 | Why? |
Consensus | 3 | 2021 | 6345 | 0.17 | Why? |
Rwanda | 1 | 2017 | 270 | 0.17 | Why? |
Middle Aged | 37 | 2021 | 270681 | 0.17 | Why? |
Female | 44 | 2021 | 380317 | 0.17 | Why? |
Anesthetics | 1 | 2020 | 196 | 0.16 | Why? |
Bronchoscopy | 1 | 2005 | 991 | 0.16 | Why? |
Severity of Illness Index | 6 | 2021 | 48226 | 0.16 | Why? |
Fasciitis, Necrotizing | 1 | 2017 | 56 | 0.16 | Why? |
Point-of-Care Systems | 2 | 2021 | 2955 | 0.16 | Why? |
Respiratory Tract Infections | 1 | 2018 | 6817 | 0.16 | Why? |
Phenotype | 2 | 2018 | 4037 | 0.16 | Why? |
Exhalation | 2 | 2017 | 441 | 0.16 | Why? |
Herpesviridae | 1 | 2017 | 100 | 0.16 | Why? |
Cellulitis | 1 | 2017 | 119 | 0.15 | Why? |
p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 230 | 0.15 | Why? |
Streptococcus pneumoniae | 2 | 2018 | 827 | 0.15 | Why? |
Intubation, Intratracheal | 2 | 2017 | 3962 | 0.15 | Why? |
Biomarkers | 14 | 2021 | 23361 | 0.15 | Why? |
Intraoperative Care | 1 | 2017 | 238 | 0.15 | Why? |
Walking | 1 | 2020 | 442 | 0.15 | Why? |
False Positive Reactions | 1 | 2021 | 1338 | 0.15 | Why? |
Laparotomy | 1 | 2017 | 241 | 0.15 | Why? |
Lipopolysaccharides | 2 | 2018 | 848 | 0.15 | Why? |
Acetylcysteine | 1 | 2018 | 255 | 0.15 | Why? |
Herpesviridae Infections | 1 | 2017 | 172 | 0.14 | Why? |
Rehabilitation | 1 | 2021 | 386 | 0.14 | Why? |
Toll-Like Receptors | 1 | 2018 | 365 | 0.14 | Why? |
Cohort Studies | 10 | 2021 | 36005 | 0.14 | Why? |
Treatment Outcome | 10 | 2021 | 51732 | 0.14 | Why? |
Goals | 1 | 2018 | 335 | 0.14 | Why? |
Intubation | 1 | 2017 | 437 | 0.14 | Why? |
Body Weight | 2 | 2018 | 1074 | 0.14 | Why? |
Drug Resistance | 1 | 2017 | 395 | 0.14 | Why? |
Aged | 29 | 2021 | 215776 | 0.14 | Why? |
Interleukin-8 | 2 | 2017 | 964 | 0.13 | Why? |
Respiratory Function Tests | 4 | 2021 | 1755 | 0.13 | Why? |
Spirometry | 1 | 2017 | 524 | 0.13 | Why? |
Nebulizers and Vaporizers | 1 | 2018 | 497 | 0.13 | Why? |
Metabolomics | 2 | 2017 | 921 | 0.13 | Why? |
False Negative Reactions | 1 | 2021 | 1785 | 0.13 | Why? |
Patient Acuity | 1 | 2021 | 1755 | 0.13 | Why? |
Europe | 5 | 2020 | 12702 | 0.13 | Why? |
Platelet Activation | 1 | 2018 | 660 | 0.13 | Why? |
Pandemics | 10 | 2020 | 389249 | 0.13 | Why? |
Calcium Channel Blockers | 1 | 2017 | 367 | 0.13 | Why? |
Diffusion of Innovation | 1 | 2018 | 440 | 0.13 | Why? |
Expert Testimony | 1 | 2017 | 658 | 0.13 | Why? |
Length of Stay | 5 | 2018 | 11042 | 0.13 | Why? |
Shock | 1 | 2020 | 1868 | 0.12 | Why? |
Advisory Committees | 1 | 2020 | 1418 | 0.12 | Why? |
Global Burden of Disease | 1 | 2017 | 531 | 0.12 | Why? |
Patient Care Planning | 1 | 2018 | 582 | 0.12 | Why? |
Inservice Training | 1 | 2017 | 477 | 0.12 | Why? |
Cyclin-Dependent Kinases | 1 | 2012 | 124 | 0.12 | Why? |
Internationality | 3 | 2020 | 3297 | 0.12 | Why? |
Body Temperature | 1 | 2018 | 875 | 0.12 | Why? |
Tomography, X-Ray Computed | 6 | 2021 | 25144 | 0.12 | Why? |
Demography | 1 | 2019 | 1660 | 0.12 | Why? |
Interleukin-6 | 3 | 2021 | 7522 | 0.12 | Why? |
Patient Selection | 2 | 2018 | 4560 | 0.11 | Why? |
Erythrocyte Aging | 1 | 2010 | 13 | 0.11 | Why? |
Acute Lung Injury | 2 | 2010 | 904 | 0.11 | Why? |
Immunomodulation | 1 | 2020 | 1472 | 0.11 | Why? |
Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
Medical Staff, Hospital | 1 | 2020 | 1258 | 0.10 | Why? |
Prebiotics | 1 | 2010 | 53 | 0.10 | Why? |
Hospital Mortality | 4 | 2018 | 22087 | 0.10 | Why? |
Robotic Surgical Procedures | 1 | 2018 | 787 | 0.10 | Why? |
Airway Management | 1 | 2020 | 1298 | 0.10 | Why? |
NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
Viremia | 1 | 2017 | 1020 | 0.10 | Why? |
International Cooperation | 2 | 2020 | 3436 | 0.10 | Why? |
Patient Care | 1 | 2020 | 1664 | 0.10 | Why? |
Infection Control | 5 | 2021 | 23131 | 0.10 | Why? |
Anticoagulants | 2 | 2021 | 9563 | 0.10 | Why? |
Research Design | 2 | 2017 | 5830 | 0.10 | Why? |
Hypoxia | 2 | 2021 | 3626 | 0.09 | Why? |
Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
Clinical Protocols | 2 | 2020 | 2734 | 0.09 | Why? |
Pneumonia | 4 | 2019 | 5652 | 0.09 | Why? |
Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
Adult | 17 | 2021 | 244371 | 0.09 | Why? |
Disseminated Intravascular Coagulation | 1 | 2017 | 994 | 0.09 | Why? |
Bacterial Load | 2 | 2018 | 179 | 0.09 | Why? |
Out-of-Hospital Cardiac Arrest | 1 | 2018 | 1047 | 0.09 | Why? |
Preoperative Period | 2 | 2019 | 271 | 0.09 | Why? |
Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 9706 | 0.09 | Why? |
Respiratory System | 2 | 2018 | 3213 | 0.08 | Why? |
Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.08 | Why? |
Multicenter Studies as Topic | 3 | 2018 | 2437 | 0.08 | Why? |
Purines | 1 | 2012 | 816 | 0.08 | Why? |
Blood Platelets | 1 | 2018 | 1704 | 0.08 | Why? |
Microbiota | 1 | 2017 | 1240 | 0.08 | Why? |
Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
Erythrocyte Transfusion | 1 | 2010 | 386 | 0.08 | Why? |
Observational Studies as Topic | 3 | 2018 | 1887 | 0.08 | Why? |
Contraindications | 1 | 2006 | 96 | 0.08 | Why? |
Time Factors | 5 | 2021 | 31397 | 0.08 | Why? |
Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
Genomics | 1 | 2017 | 3118 | 0.07 | Why? |
APACHE | 2 | 2018 | 682 | 0.07 | Why? |
Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.07 | Why? |
Sex Factors | 2 | 2019 | 11014 | 0.07 | Why? |
Prognosis | 4 | 2021 | 32490 | 0.07 | Why? |
Patient Discharge | 1 | 2021 | 5696 | 0.07 | Why? |
Sensitivity and Specificity | 3 | 2021 | 22971 | 0.07 | Why? |
Double-Blind Method | 3 | 2021 | 5988 | 0.07 | Why? |
Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
Societies, Medical | 1 | 2020 | 6907 | 0.07 | Why? |
Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
Clinical Laboratory Techniques | 2 | 2021 | 23402 | 0.06 | Why? |
Surgical Procedures, Operative | 1 | 2019 | 2662 | 0.06 | Why? |
Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
ROC Curve | 3 | 2021 | 6024 | 0.06 | Why? |
Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
Radiography, Thoracic | 1 | 2019 | 5486 | 0.06 | Why? |
Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
Immunization, Passive | 1 | 2018 | 10067 | 0.06 | Why? |
Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
Models, Biological | 1 | 2019 | 4907 | 0.06 | Why? |
Personal Protective Equipment | 3 | 2021 | 15978 | 0.06 | Why? |
Blood Gas Analysis | 1 | 2005 | 893 | 0.06 | Why? |
Risk Factors | 7 | 2021 | 71621 | 0.06 | Why? |
Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.05 | Why? |
Urinary Tract Infections | 1 | 2007 | 534 | 0.05 | Why? |
Systemic Inflammatory Response Syndrome | 2 | 2018 | 6653 | 0.05 | Why? |
Mass Screening | 1 | 2021 | 8005 | 0.05 | Why? |
Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
Apnea | 1 | 2020 | 58 | 0.05 | Why? |
Communication | 1 | 2018 | 5206 | 0.05 | Why? |
Retrospective Studies | 9 | 2021 | 105322 | 0.05 | Why? |
Biomedical Research | 2 | 2017 | 5270 | 0.05 | Why? |
Capillary Permeability | 1 | 2021 | 277 | 0.05 | Why? |
Healthcare Disparities | 1 | 2017 | 3893 | 0.05 | Why? |
Hyperglycemia | 1 | 2010 | 1363 | 0.05 | Why? |
Urinalysis | 1 | 2021 | 218 | 0.05 | Why? |
Intraoperative Period | 1 | 2018 | 97 | 0.05 | Why? |
Helminth Proteins | 1 | 2018 | 32 | 0.05 | Why? |
Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
Bronchoalveolar Lavage Fluid | 2 | 2018 | 2309 | 0.05 | Why? |
Placebos | 1 | 2021 | 629 | 0.04 | Why? |
Work of Breathing | 1 | 2018 | 86 | 0.04 | Why? |
Chemokine CX3CL1 | 1 | 2017 | 26 | 0.04 | Why? |
Inflammation | 2 | 2018 | 13255 | 0.04 | Why? |
Membrane Glycoproteins | 1 | 2007 | 2273 | 0.04 | Why? |
Heparin | 2 | 2021 | 2600 | 0.04 | Why? |
Specific Pathogen-Free Organisms | 1 | 2018 | 358 | 0.04 | Why? |
Drug Prescriptions | 1 | 2006 | 1062 | 0.04 | Why? |
Electric Impedance | 1 | 2019 | 283 | 0.04 | Why? |
Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.04 | Why? |
Calibration | 1 | 2018 | 307 | 0.04 | Why? |
Reproducibility of Results | 3 | 2018 | 11304 | 0.04 | Why? |
Gene Expression Regulation | 2 | 2021 | 4020 | 0.04 | Why? |
Operative Time | 1 | 2018 | 450 | 0.04 | Why? |
Gas Chromatography-Mass Spectrometry | 1 | 2017 | 187 | 0.04 | Why? |
Acute Disease | 2 | 2021 | 6029 | 0.04 | Why? |
Rats | 2 | 2017 | 2764 | 0.04 | Why? |
Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
Receptors, Immunologic | 2 | 2012 | 555 | 0.04 | Why? |
Wakefulness | 1 | 2021 | 598 | 0.04 | Why? |
Sample Size | 1 | 2018 | 518 | 0.04 | Why? |
Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
Tertiary Care Centers | 3 | 2017 | 8248 | 0.04 | Why? |
Peritoneal Dialysis | 1 | 2021 | 498 | 0.04 | Why? |
Random Allocation | 1 | 2017 | 773 | 0.04 | Why? |
Hospitals, University | 2 | 2018 | 4173 | 0.03 | Why? |
Muscle Strength | 1 | 2017 | 317 | 0.03 | Why? |
Pulmonary Gas Exchange | 1 | 2017 | 414 | 0.03 | Why? |
Health Personnel | 3 | 2021 | 29646 | 0.03 | Why? |
Remission Induction | 1 | 2018 | 950 | 0.03 | Why? |
Positron-Emission Tomography | 1 | 2019 | 802 | 0.03 | Why? |
Infant | 1 | 2017 | 30274 | 0.03 | Why? |
Reference Standards | 1 | 2018 | 1163 | 0.03 | Why? |
Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
Developed Countries | 1 | 2017 | 500 | 0.03 | Why? |
Influenza A Virus, H3N2 Subtype | 1 | 2018 | 572 | 0.03 | Why? |
RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.03 | Why? |
Antithrombins | 1 | 2017 | 353 | 0.03 | Why? |
Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
Pleural Effusion | 1 | 2019 | 680 | 0.03 | Why? |
Follow-Up Studies | 2 | 2018 | 17020 | 0.03 | Why? |
Ventilation | 1 | 2020 | 1145 | 0.03 | Why? |
Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
Risk Assessment | 3 | 2019 | 25439 | 0.03 | Why? |
Fluid Therapy | 1 | 2017 | 628 | 0.03 | Why? |
Nepal | 1 | 2017 | 1004 | 0.03 | Why? |
Mice | 3 | 2018 | 21357 | 0.03 | Why? |
Animals | 6 | 2018 | 78931 | 0.03 | Why? |
Lipocalins | 1 | 2011 | 19 | 0.03 | Why? |
Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
Trachea | 1 | 2017 | 894 | 0.03 | Why? |
Disease Models, Animal | 3 | 2018 | 10998 | 0.03 | Why? |
Administration, Inhalation | 1 | 2018 | 1647 | 0.03 | Why? |
Income | 1 | 2021 | 1564 | 0.03 | Why? |
Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
Bangladesh | 1 | 2017 | 1620 | 0.03 | Why? |
Asia | 1 | 2018 | 2399 | 0.03 | Why? |
Pneumothorax | 1 | 2019 | 758 | 0.03 | Why? |
Dysbiosis | 1 | 2017 | 685 | 0.03 | Why? |
Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
Signal Transduction | 2 | 2018 | 7207 | 0.03 | Why? |
Cystatin C | 1 | 2011 | 125 | 0.03 | Why? |
Acute-Phase Proteins | 1 | 2011 | 177 | 0.03 | Why? |
Lipocalin-2 | 1 | 2011 | 156 | 0.03 | Why? |
Hand Hygiene | 1 | 2020 | 1493 | 0.03 | Why? |
Interleukin-10 | 1 | 2017 | 1409 | 0.03 | Why? |
Genome-Wide Association Study | 1 | 2017 | 1648 | 0.03 | Why? |
Cluster Analysis | 1 | 2018 | 3001 | 0.03 | Why? |
Lymphocyte Subsets | 1 | 2017 | 987 | 0.03 | Why? |
Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
Pneumonia, Bacterial | 1 | 2017 | 843 | 0.02 | Why? |
Proto-Oncogene Proteins | 1 | 2011 | 340 | 0.02 | Why? |
Sodium Chloride | 1 | 2010 | 203 | 0.02 | Why? |
Early Diagnosis | 1 | 2017 | 2443 | 0.02 | Why? |
Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
Delayed Diagnosis | 1 | 2018 | 1529 | 0.02 | Why? |
United States | 3 | 2020 | 46150 | 0.02 | Why? |
Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2007 | 40 | 0.02 | Why? |
Rats, Sprague-Dawley | 1 | 2010 | 987 | 0.02 | Why? |
Elective Surgical Procedures | 1 | 2005 | 5338 | 0.02 | Why? |
Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
Endothelial Cells | 1 | 2017 | 2048 | 0.02 | Why? |
Lung Injury | 1 | 2016 | 919 | 0.02 | Why? |
Age Factors | 2 | 2018 | 21039 | 0.02 | Why? |
Chromatography, High Pressure Liquid | 1 | 2010 | 669 | 0.02 | Why? |
Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
Cytokines | 2 | 2018 | 15010 | 0.02 | Why? |
Poverty | 1 | 2017 | 2302 | 0.02 | Why? |
Antibodies, Viral | 1 | 2018 | 51949 | 0.02 | Why? |
Community-Acquired Infections | 1 | 2017 | 2328 | 0.02 | Why? |
General Surgery | 1 | 2017 | 1472 | 0.02 | Why? |
Health Status | 1 | 2018 | 3259 | 0.02 | Why? |
Australia | 1 | 2018 | 6306 | 0.02 | Why? |
Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
Mass Spectrometry | 1 | 2010 | 1165 | 0.02 | Why? |
Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
Hypoglycemic Agents | 1 | 2017 | 2165 | 0.02 | Why? |
HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
Patient Care Team | 1 | 2018 | 3556 | 0.02 | Why? |
Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
Machine Learning | 1 | 2019 | 4395 | 0.02 | Why? |
Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
Apoptosis | 1 | 2012 | 2335 | 0.01 | Why? |
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3832 | 0.01 | Why? |
Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.01 | Why? |
Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
Cells, Cultured | 1 | 2012 | 5835 | 0.01 | Why? |
Cross-Sectional Studies | 2 | 2019 | 53120 | 0.01 | Why? |
Brain | 1 | 2017 | 5133 | 0.01 | Why? |
Attitude of Health Personnel | 1 | 2017 | 4741 | 0.01 | Why? |
India | 1 | 2017 | 11875 | 0.01 | Why? |
Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
Heart Failure | 1 | 2019 | 6638 | 0.01 | Why? |
Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
Viral Load | 1 | 2018 | 15850 | 0.01 | Why? |
Registries | 1 | 2017 | 12327 | 0.01 | Why? |
Emergency Service, Hospital | 1 | 2021 | 14232 | 0.01 | Why? |
Neutrophils | 1 | 2012 | 5476 | 0.01 | Why? |
Diabetes Mellitus | 1 | 2017 | 8207 | 0.01 | Why? |
Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
Prevalence | 1 | 2016 | 25773 | 0.01 | Why? |
Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |
Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |